...
机译:长期使用依那西普治疗甲氨蝶呤难治性多关节病幼年特发性关节炎的安全性和有效性
Department of Pediatrics, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan;
Kagoshima University School of Medicine, Kagoshima, Japan;
Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Japan;
Kagoshima University School of Medicine, Kagoshima, Japan;
Kagoshima University School of Medicine, Kagoshima, Japan;
Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Japan;
Kagoshima University School of Medicine, Kagoshima, Japan;
Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Japan;
Pfizer Inc., Tokyo, Japan;
Pfizer Inc., Tokyo, Japan;
Pfizer Inc., Collegeville, PA, USA;
Pfizer Inc., Collegeville, PA, USA;
Anti-TNF agent; Etanercept; Juvenile idiopathic arthritis; Polyarticular course;
机译:长期使用依那西普治疗甲氨蝶呤难治性多关节病幼年特发性关节炎的安全性和有效性
机译:短期(12周)依那西普治疗甲氨蝶呤难治性多关节青少年特发性关节炎的药代动力学,疗效和安全性
机译:英夫利昔单抗加甲氨蝶呤治疗多关节病幼年类风湿关节炎的长期疗效和安全性:开放标签治疗的发现。
机译:依赖替辛醚治疗少年类风湿性关节炎中AA淀粉样液 - 初步体验
机译:从青少年特发性关节炎服用特发性
机译:简明报告:英夫利昔单抗加甲氨蝶呤治疗多关节病幼年类风湿关节炎的长期疗效和安全性:开放标签治疗的发现
机译:英夫利昔单抗加甲氨蝶呤治疗多关节病幼年类风湿关节炎的长期疗效和安全性:开放标签治疗的发现